Delivery Order SPE2DB22D1106-SPE2DB25FFDX3
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,124.66 by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 4, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,003.47. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,717.72 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to...
- This is a $1,664.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Topiramate ER 100 mg capsules. The contract has an ultimate completion date of July 10, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDX3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse medications, vaccines, and medical supplies to military healthcare systems and other federal medical programs worldwide. AmerisourceBergen's track record of competitively awarded delivery orders across multiple therapeutic domains—including neurological treatments, diabetes medications, and pain management pharmaceuticals—demonstrates the company's established capability as a critical federal pharmaceutical vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/18/25 |